TY - JOUR
T1 - Consequences of a telomerase-related fitness defect and chromosome substitution technology in yeast synIX strains
AU - McCulloch, Laura H.
AU - Sambasivam, Vijayan
AU - Hughes, Amanda L.
AU - Annaluru, Narayana
AU - Ramalingam, Sivaprakash
AU - Fanfani, Viola
AU - Lobzaev, Evgenii
AU - Mitchell, Leslie A
AU - Cai, Jitong
AU - Build-A-Genome Class
AU - Jiang, Hua
AU - LaCava, John
AU - Taylor, Martin S.
AU - Bishai, William R.
AU - Stracquadanio, Giovanni
AU - Steinmetz, Lars M.
AU - Bader, Joel S.
AU - Zhang, Weimin
AU - Boeke, Jef D.
AU - Chandrasegaran, Srinivasan
N1 - Funding Information:
We thank Meghan O’Keefe for collecting the BAG student authors’ information. The work reported here forms a portion of L.H.M.’s PhD thesis. We thank the NSF for grants MCB-1026068 , MCB-1443299 , MCB-1616111 , and MCB-1921641 to J.D.B. and MCB-1445545 to J.S.B., which support this work.
Funding Information:
We thank Meghan O'Keefe for collecting the BAG student authors’ information. The work reported here forms a portion of L.H.M.’s PhD thesis. We thank the NSF for grants MCB-1026068, MCB-1443299, MCB-1616111, and MCB-1921641 to J.D.B. and MCB-1445545 to J.S.B. which support this work. J.D.B. S.C. and W.Z. conceptualized the study. W.Z. S.C. L.H.M. and J.D.B. designed the experiments. J.D.B. and J.S.B. designed synIX. The Build-A-Genome class members constructed building blocks. V.S. N.A. and S.R. constructed minichunks and incorporated them for megachunks A–F. L.H.M. designed, constructed, and delivered megachunks G–I and performed error correction, bug mapping, bug correction, and functional studies of synIX. L.H.M. and W.Z. developed and evaluated the chromosome substitution method. L.H.M. A.L.H. J.C. V.F. E.L. and G.S. performed sequencing and data analyses. L.H.M. W.Z. and J.D.B. wrote the manuscript. L.A.M. H.J. J.L. M.S.T. and W.R.B. provided advice. S.C. J.D.B. J.S.B. and L.M.S. provided lab supervision. All authors reviewed and edited the manuscript. J.D.B. is a founder and director of CDI Labs, Inc. a founder of and consultant to Neochromosome, Inc, a founder, SAB member of, and consultant to ReOpen Diagnostics, LLC, and serves or served on the scientific advisory board of the following: Logomix, Inc. Sangamo, Inc. Modern Meadow, Inc. Rome Therapeutics, Inc. Sample6, Inc. Tessera Therapeutics, Inc. and the Wyss Institute. J.S.B. is a founder of Neochromosome, Inc. consultant to Opentrons Labworks, Inc. and advisor to Reflexion Pharmaceuticals, Inc.
Publisher Copyright:
© 2023 The Authors
PY - 2023/11/8
Y1 - 2023/11/8
N2 - We describe the complete synthesis, assembly, debugging, and
characterization of a synthetic 404,963 bp chromosome, synIX (synthetic
chromosome IX). Combined chromosome construction methods were used to
synthesize and integrate its left arm (synIXL) into a strain containing
previously described synIXR. We identified and resolved a bug affecting
expression of EST3, a crucial gene for telomerase function, producing a synIX
strain with near wild-type fitness. To facilitate future synthetic chromosome
consolidation and increase flexibility of chromosome transfer between distinct
strains, we combined chromoduction, a method to transfer a whole chromosome
between two strains, with conditional centromere destabilization to substitute
a chromosome of interest for its native counterpart. Both steps of this
chromosome substitution method were efficient. We observed that wild-type II
tended to co-transfer with synIX and was co-destabilized with wild-type IX,
suggesting a potential gene dosage compensation relationship between these
chromosomes.
AB - We describe the complete synthesis, assembly, debugging, and
characterization of a synthetic 404,963 bp chromosome, synIX (synthetic
chromosome IX). Combined chromosome construction methods were used to
synthesize and integrate its left arm (synIXL) into a strain containing
previously described synIXR. We identified and resolved a bug affecting
expression of EST3, a crucial gene for telomerase function, producing a synIX
strain with near wild-type fitness. To facilitate future synthetic chromosome
consolidation and increase flexibility of chromosome transfer between distinct
strains, we combined chromoduction, a method to transfer a whole chromosome
between two strains, with conditional centromere destabilization to substitute
a chromosome of interest for its native counterpart. Both steps of this
chromosome substitution method were efficient. We observed that wild-type II
tended to co-transfer with synIX and was co-destabilized with wild-type IX,
suggesting a potential gene dosage compensation relationship between these
chromosomes.
U2 - 10.1016/j.xgen.2023.100419
DO - 10.1016/j.xgen.2023.100419
M3 - Article
C2 - 38020974
SN - 2666-979X
VL - 3
JO - Cell Genomics
JF - Cell Genomics
IS - 11
M1 - 100419
ER -